Carbon Waters has announced a major milestone with the installation of its first production unit at its facility in Pessac.
Oct 3, 2024
Versarien has announced that it has signed an agreement with Balfour Beatty Group to develop a range of low carbon, graphene-infused, 3D-printable mortars suitable for civil construction.
Oct 3, 2024
Too warm with a jacket on but too cold without it? Athletic apparel brands boast temperature-controlling fabrics that adapt to every climate with lightweight but warm products. Yet, consider a fabric that you can adjust to fit your specific temper...
Oct 2, 2024
Imagine trying to poke a hole in the yolk of a raw egg without breaking the egg white. It sounds impossible, but researchers at the University of California San Diego have developed a technology that performs a similarly delicate task in living ce...
Oct 2, 2024
Imagine a material that doesn’t just respond to one stimulus, like heat or light, but can sense multiple environmental triggers and adjust its behavior accordingly. Picture this material not only changing its shape in response but also performing ...
Oct 2, 2024
The UK semiconductor industry has received a significant boost as Innovate UK, a part of UK Research and Innovation, has announced an investment of £11.5 million spread across 16 innovative projects. This funding is aimed at scaling up semiconduct...
Oct 2, 2024
Versarien has announced the completed sale of its wholly-owned subsidiary AAC Cyroma to Harper Bennett for £0.55 million (around USD$734,000).
Oct 1, 2024
Small interfering RNA (siRNA) molecules hold immense potential for treating diseases by silencing specific genes. Encapsulated in lipid nanoparticles (LNPs), siRNA can be delivered efficiently to target cells.
Oct 1, 2024
Scientists at TU Delft and the Max Planck Institute have made a new class of structurally adaptable 'mechanical' pores made from DNA that can transport molecules through cell membranes. These innovative nanopores can open and close on de...
Oct 1, 2024
Penn Engineers have discovered a novel means of directing lipid nanoparticles (LNPs), the revolutionary molecules that delivered the COVID-19 vaccines, to target specific tissues, presaging a new era in personalized medicine and gene therapy.
Oct 1, 2024
